GSK responds to Elliott Advisors

Monday 5 July 2021

United Kingdom

The board of directors of GlaxoSmithKline Plc has issued a strong endorsement of the company’s chief executive Emma Walmsley a day after activist investor Elliott Advisors called on it to appoint new members and review the executive leadership at the company.

Read in full with a subscription

Learn more about subscribing to MedNous.